Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 14;20(5):e0322581.
doi: 10.1371/journal.pone.0322581. eCollection 2025.

The effect of early pregnancy ALT elevation on neonatal birth weight: The mediating role of gestational diabetes mellitus

Affiliations

The effect of early pregnancy ALT elevation on neonatal birth weight: The mediating role of gestational diabetes mellitus

Wen-Xia Ma et al. PLoS One. .

Abstract

Elevated serum alanine aminotransferase (ALT) levels in early pregnancy and gestational diabetes mellitus (GDM) are linked to an increased rate of large for gestational age (LGA) births. Additionally, elevated ALT levels raise the risk of developing GDM, but it remains unclear whether GDM mediates the effect of ALT on neonatal birth weight. This study examines whether GDM mediates this relationship. We conducted a retrospective cohort study with participants from Jinxin Women's and Children's Hospital who delivered single live births between 2020 and 2023. A multifactorial logistic regression model assessed the relationship between early pregnancy ALT levels, GDM incidence, and LGA births. A mediation model evaluated GDM's role in the impact of elevated ALT on neonatal birth weight. Our study included 12,057 patients. After adjusting for confounders, the difference in LGA rates between elevated and normal ALT groups was significant (OR: 1.248, 95% CI: 1.001-1.556, P = 0.049). The GDM incidence difference between these groups was also significant (OR: 1.564, 95% CI: 1.306-1.873, P < 0.01), as was the LGA incidence difference between GDM and non-GDM groups (OR: 1.306, 95% CI: 1.129-1.511, P < 0.01). After adjusting for confounders, we found that elevated ALT levels in early pregnancy and GDM both affected neonatal birth weight. Specifically, elevated ALT levels had a direct impact on neonatal birth weight (β = 0.0291, 95% CI: 0.0100-0.0635), while GDM had an indirect effect (β = 0.0025, 95% CI: 0.0012-0.0056), with GDM accounting for 8.1% of the mediation effect. Our study shows that GDM partly mediates the effect of elevated ALT on neonatal birth weight, highlighting the importance of early ALT and glucose screening in routine prenatal care. Healthcare providers should consider including ALT testing in pregnancy protocols and focus on blood glucose control in patients with elevated ALT to reduce the risk of LGA births.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Research process flowchart.
Explained the research process and key steps of this study.
Fig 2
Fig 2. Estimated proportion of association between early pregnancy ALT levels mediated by GDM and LGA.
IE = indirect effect, DE = direct effect.Adjusted: age, BMI, pregnancy weight gain, delivery gestational week, nulliparous, assisted reproduction, pregnancy hypertension, and pre-existing diabetes.

Similar articles

Cited by

References

    1. Macrosomia: ACOG Practice Bulletin, Number 216. Obstet Gynecol. 2020;135(1):e18–35. doi: 10.1097/AOG.0000000000003606 - DOI - PubMed
    1. Scifres CM. Short- and Long-Term Outcomes Associated with Large for Gestational Age Birth Weight. Obstet Gynecol Clin North Am. 2021;48(2):325–37. doi: 10.1016/j.ogc.2021.02.005 - DOI - PubMed
    1. Yarrington CD, Cantonwine DE, Seely EW, Mcelrath TF, Zera CA. The association of early unexplained elevated alanine aminotransferase with large-for-gestational-age birthweight. Am J Obstet Gynecol. 2016;215(4):474.e1-5. doi: 10.1016/j.ajog.2016.04.051 - DOI - PubMed
    1. Lee SM, Kim BJ, Koo JN, Norwitz ER, Oh IH, Kim SM, et al.. Nonalcoholic fatty liver disease is a risk factor for large-for-gestational-age birthweight. PLoS One. 2019;14(8):e0221400. doi: 10.1371/journal.pone.0221400 - DOI - PMC - PubMed
    1. Tran TT, Ahn J, Reau NS. ACG Clinical Guideline: Liver Disease and Pregnancy. Am J Gastroenterol. 2016;111(2):176–94; quiz 196. doi: 10.1038/ajg.2015.430 - DOI - PubMed

Substances